Company profile: Allergopharma
1.1 - Company Overview
Company description
- Provider of allergen-specific immunotherapy for type 1 allergies such as hay fever and allergic asthma, offering Allergen Immunotherapy (AIT) to induce immunological tolerance, reduce symptoms, and prevent the progression of allergic diseases, along with diagnostics for IgE-mediated allergies to identify triggers for targeted treatment.
Products and services
- Diagnostics for IgE-mediated Allergies: Delivers IgE-mediated diagnostics tools and tests that identify specific allergy triggers, essential for targeted allergy treatment of type 1 allergies including hay fever and allergic asthma
- Allergen Immunotherapy (AIT): Allergen-specific therapy inducing immunological tolerance to type 1 allergy triggers, addressing root cause, reducing symptoms, and preventing progression of allergic diseases like hay fever or allergic asthma
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Allergopharma
BioXell
HQ: Italy
Website
- Description: Provider of recombinant protein expression and purification services; stable cell line generation using proprietary ExoIN technology and cGMP-compliant CHO-based platforms; transient protein expression; customized protein expression screening; high-yield recombinant protein production in E. coli, yeast, and mammalian systems; and monoclonal and polyclonal antibody development via hybridoma and phage display.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioXell company profile →
SetPoint Medical
HQ: United States
Website
- Description: Provider of neuroimmune modulation solutions for chronic autoimmune conditions, including a platform that activates immunomodulatory pathways via targeted electrical stimulation to regulate inflammation, and a small vagus nerve stimulation device with integrated circuit, telemetry and rechargeable battery controlled via iPad. Also conducts clinical research, including RESET-RA, a randomized, double-blind rheumatoid arthritis study.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SetPoint Medical company profile →
Avidia
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies focused on discovering and developing therapeutic proteins. Offers Avimer therapeutic proteins addressing multiple therapeutic areas, including autoimmunity, inflammation, oncology, and neurology. Founded in 2003 and headquartered in Mountain View, California.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avidia company profile →
Alumis
HQ: United States
Website
- Description: Provider of precision medicine solutions focused on the discovery, development, and treatment of autoimmune disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alumis company profile →
Greer Laboratories
HQ: United States
Website
- Description: Provider of subcutaneous immunotherapy and allergenic extracts for allergy diagnosis and treatment, including non-standardized extracts; short ragweed pollen and short/giant ragweed pollen mix extracts; standardized cat hair extracts for asthma, rhinitis, and conjunctivitis; and standardized grass pollen extracts for skin test diagnosis and immunotherapy to reduce allergic symptoms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Greer Laboratories company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Allergopharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Allergopharma
2.2 - Growth funds investing in similar companies to Allergopharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Allergopharma
4.2 - Public trading comparable groups for Allergopharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →